Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
METAZ 30GM CREAM
- Sku : I-003817
Key features
METAZ 30GM CREAM is a topical cream containing mometasone furoate 0.10%. It is a topical glucocorticoid that binds intracellular glucocorticoid receptors and modulates gene transcription to suppress inflammatory mediators, including inhibition of phospholipase A2 and reduced prostaglandin and leukotriene production, producing anti-inflammatory, antipruritic and vasoconstrictive effects. It is indicated for the relief of inflammatory and pruritic manifestations of steroid‑responsive dermatoses such as eczema, psoriasis and contact dermatitis. Available as a prescription 30 g cream.- Brand: METAZ
- Active Ingredient: MOMETASONE FUROATE
- Strength: 0.10%
- Dosage Form: Cream
- Pack Size: 30 g
- Route: Topical
- Prescription Status: Prescription
- Therapeutic Class: Dermatological
- Pharmacological Group: Corticosteroids (Plain)
- Manufacturer: SPIMACO
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2405233715
- Shelf Life: 36 months
- Storage: store below 25°c
- Skin Condition: Eczema, Psoriasis, Allergic/Contact Dermatitis
- Steroid Potency: Potent
Frequently bought together
Dosage & Administration
Dosing by Condition
For corticosteroid-responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin layer to affected areas once daily; reassess if not improved within ~2 weeks and avoid prolonged continuous use.
Maximum Dose
Apply a thin layer once daily; reassess if no improvement within ~2 weeks; avoid prolonged use on the face/intertriginous areas and in children (generally limit to short courses, e.g., ≤5 days on face/children unless specialist-directed).
Dose Adjustment Notes
Use the lowest effective amount for the shortest duration; once control is achieved, reduce frequency or discontinue; if HPA-axis suppression or significant adverse effects occur, withdraw, reduce frequency, or switch to a less potent steroid; use extra caution on face/flexures and avoid occlusion unless directed.
How to Take
Apply a thin layer to the affected skin once daily and rub in gently; wash hands before and after application (unless treating hands); avoid contact with eyes, mouth, and other mucous membranes; do not use on the face, groin, or axillae or under occlusion/airtight dressings unless directed by a prescriber; apply to affected areas only.
Side Effects
Common Side Effects
Application-site burning, stinging/tingling, pruritus, irritation/dryness; folliculitis/furunculosis; with prolonged or extensive use: skin atrophy, striae, telangiectasia.
Safety & Warnings
Contraindications
Hypersensitivity to mometasone furoate or excipients; untreated bacterial/viral/fungal/parasitic skin infections; skin tuberculosis; cutaneous syphilis; post-vaccination skin reactions; rosacea; perioral dermatitis; acne vulgaris.
Drug Interactions
Drug Interactions
No clinically significant interactions expected with normal topical use; caution with concurrent topical/systemic corticosteroids and with occlusion (increases systemic absorption).
Food Interaction
No restriction
Alcohol Interaction
Safe
Special Populations
Pregnancy
Caution
Breastfeeding
Caution
Kidney Impairment
No adjustment needed
Storage & Patient Advice
Missed Dose
Apply when remembered; if it is close to the next scheduled application, skip the missed dose and resume the regular schedule; do not apply extra to make up for a missed dose.
Monitoring Requirements
Monitor clinical response and local adverse effects (atrophy, striae, telangiectasia, irritation, secondary infection); in patients using large amounts, large surface areas, prolonged courses, in children, or under occlusion, periodically assess for HPA-axis suppression and consider growth monitoring in children on long-term/repeated courses.
Pharmacology
Mechanism of Action
Topical glucocorticoid: binds intracellular glucocorticoid receptors, alters gene transcription to suppress inflammatory cytokines and mediators (including via inhibition of phospholipase A2 and reduced prostaglandin/leukotriene production), producing anti-inflammatory, antipruritic, and vasoconstrictive effects.
Metabolism
Rapid, extensive hepatic metabolism (predominantly via CYP3A4) to inactive metabolites.
Protein Binding
Approximately 98-99% (systemic protein binding).
Product Information
Available Dosage Forms
Cream, Ointment, Lotion, Nasal spray (other manufacturers/formulations)
Skin Condition
Eczema, Psoriasis, Allergic/Contact Dermatitis
Steroid Potency
Potent
Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.-1744229570.gif)














